Advanced
search

Search results

1 – 10 of 31
View access options
Executive summary
Publication date: 6 October 2015
Expert Briefings Powered by Oxford Analytica

UNITED STATES: Congress may derail TPP implementation
View access options
Expert briefing
Publication date: 4 August 2021
Expert Briefings Powered by Oxford Analytica

Bolsonaro has been increasing his attacks on senators leading a Senate-led inquiry into his administration’s handling of COVID-19 and on members of the Supreme Court and the TSE…

Details

DOI: 10.1108/OXAN-DB263244

ISSN: 2633-304X

Keywords

Geographic
Brazil
LA/C
Topical
industry
politics
social
constitution
corruption
election
government
health
judicial
legislation
military
opposition
pharmaceutical
protest
View access options
Expert briefing
Publication date: 19 October 2015
Expert Briefings Powered by Oxford Analytica

The Obama administration faces an uphill fight in Congress to secure enough votes for TPP ratification, given Democratic suspicions of free trade agreements, Republican animus for…

View access options
Executive summary
Publication date: 5 March 2021
Expert Briefings Powered by Oxford Analytica

BRAZIL: Rio imposes curfew as Bolsonaro fumes

Details

DOI: 10.1108/OXAN-ES259994

ISSN: 2633-304X

Keywords

Geographic
Brazil
LA/C
Topical
economy
industry
politics
social
election
government
health
opposition
pharmaceutical
regional
regulation
welfare
banking
View access options
Executive summary
Publication date: 10 November 2020
Expert Briefings Powered by Oxford Analytica

BRAZIL: Vaccines will become salient political issue

Details

DOI: 10.1108/OXAN-ES257455

ISSN: 2633-304X

Keywords

Geographic
Brazil
LA/C
China
Topical
industry
politics
social
government
health
opposition
pharmaceutical
regional
regulation
election
View access options
Executive summary
Publication date: 31 March 2021
Expert Briefings Powered by Oxford Analytica

ARGENTINA: New COVID-19 wave will pressure government

Details

DOI: 10.1108/OXAN-ES260582

ISSN: 2633-304X

Keywords

Geographic
Argentina
LA/C
Topical
industry
politics
social
election
government
health
opposition
pharmaceutical
protest
View access options
Expert briefing
Publication date: 18 June 2021
Expert Briefings Powered by Oxford Analytica

At the same time, a new Central Bank report suggests that, despite a sharp liquidity-driven economic rebound this year, the country faces a lean medium-term outlook.

Details

DOI: 10.1108/OXAN-DB262200

ISSN: 2633-304X

Keywords

Geographic
Chile
LA/C
Topical
economy
industry
politics
social
constitution
election
fiscal
government
growth
health
monetary
opposition
party
pensions
pharmaceutical
policy
prices
View access options
Expert briefing
Publication date: 2 July 2021
Expert Briefings Powered by Oxford Analytica

This would require rebuilding bridges with some moderate figures, in order to gain support among the 57 million voters who rejected his party in 2018. However, it also requires a…

Details

DOI: 10.1108/OXAN-DB262518

ISSN: 2633-304X

Keywords

Geographic
Brazil
LA/C
Topical
economy
industry
politics
social
corruption
election
fiscal
government
health
legislation
opposition
party
pharmaceutical
policy
welfare
View access options
Executive summary
Publication date: 19 February 2021
Expert Briefings Powered by Oxford Analytica

BOLIVIA: Pandemic response to become more politicised
View access options
Expert briefing
Publication date: 17 August 2016
Expert Briefings Powered by Oxford Analytica

Post-default politics in Puerto Rico.

Access

Year

Content type

Refine By Country
{"A":[{"count":"3","title":"Argentina","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Argentina%22"}],"B":[{"count":"1","title":"Barbados","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Barbados%22"},{"count":"2","title":"Bolivia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Bolivia%22"},{"count":"11","title":"Brazil","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Brazil%22"}],"C":[{"count":"3","title":"Canada","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Canada%22"},{"count":"1","title":"Caribbean","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Caribbean%22"},{"count":"2","title":"Chile","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Chile%22"},{"count":"7","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22China%22"}],"F":[{"count":"1","title":"France","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22France%22"}],"G":[{"count":"1","title":"Guyana","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Guyana%22"}],"H":[{"count":"1","title":"Hungary","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Hungary%22"}],"J":[{"count":"1","title":"Jamaica","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Jamaica%22"},{"count":"2","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Japan%22"}],"M":[{"count":"1","title":"Malaysia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Malaysia%22"},{"count":"1","title":"Mercosur","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Mercosur%22"},{"count":"2","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Mexico%22"},{"count":"1","title":"Myanmar","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Myanmar%22"}],"N":[{"count":"1","title":"New Zealand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22New+Zealand%22"}],"P":[{"count":"1","title":"Paraguay","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Paraguay%22"},{"count":"2","title":"Peru","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Peru%22"},{"count":"1","title":"Puerto Rico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Puerto+Rico%22"}],"R":[{"count":"1","title":"Russia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Russia%22"}],"S":[{"count":"1","title":"Saint Kitts and Nevis","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Saint+Kitts+and+Nevis%22"},{"count":"1","title":"Saint Lucia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Saint+Lucia%22"},{"count":"1","title":"Saint Vincent","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Saint+Vincent%22"},{"count":"1","title":"Sweden","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Sweden%22"}],"T":[{"count":"1","title":"Thailand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Thailand%22"}],"U":[{"count":"1","title":"United Kingdom","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22United+Kingdom%22"},{"count":"10","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22United+States%22"},{"count":"1","title":"Uruguay","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Uruguay%22"}],"V":[{"count":"4","title":"Venezuela","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Venezuela%22"},{"count":"1","title":"Vietnam","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-topical%3A%22election%22+AND+keyword-country%3A%22Vietnam%22"}]}
1 – 10 of 31
Manage cookies

We’re listening — tell us what you think

Join us on our journey